Related Experiment Video

Updated: Mar 16, 2026

Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
05:16

Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors

Published on: February 19, 2022

6.7K

Management of Gastrointestinal Stromal Tumors

Margaret von Mehren1

  • 1Department of Hematology/Oncology, Fox Chase Cancer Center, C-218, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

The Surgical Clinics of North America
|August 21, 2016
PubMed

Insights

Gastrointestinal stromal tumors (GISTs) management has improved with tyrosine kinase inhibitors, shifting focus from surgery alone. Treatment decisions now integrate risk, pathology, and tumor location for better outcomes.

Area of Science:

  • Oncology
  • Gastrointestinal Surgery
  • Molecular Biology

Background:

  • Gastrointestinal stromal tumors (GISTs) were historically associated with poor prognoses due to limited nonsurgical treatment options.
  • The identification of activating mutations in receptor tyrosine kinases (RTKs) revolutionized the understanding of GIST biology and treatment strategies.

Purpose of the Study:

  • To review the evolving roles of surgery and systemic therapy in managing GISTs.
  • To incorporate risk stratification into treatment decision-making for GIST patients.

Main Methods:

  • Review of current literature and clinical practices regarding GIST management.
  • Integration of risk assessment, pathologic features, and tumor location in treatment planning.

Main Results:

  • The advent of tyrosine kinase inhibitors (TKIs) since 2000 has dramatically improved GIST outcomes.
  • The role of surgical intervention is being refined in conjunction with systemic therapies.
  • Treatment decisions are increasingly guided by a comprehensive assessment of tumor characteristics and patient risk.

Conclusions:

  • Modern GIST management combines optimized surgical approaches with targeted systemic therapies.
  • Risk stratification is crucial for tailoring treatment strategies and improving patient prognoses.
Keywords:
Adjuvant therapyGISTKITMetastasectomyNeoadjuvant therapyPDGFRASDH-deficient GISTTyrosine kinase inhibitors

More Related Videos

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor07:21

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Published on: May 2, 2022

2.7K

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
808
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
1.1K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
607